Evidence map›Paper›PMID 42585262›Full record

ArticlePLoS pathogens2026

Spatial dynamics of viral replication drive biphasic lymphoid activation and systemic alphavirus immune responses.

Melaina L Jacoby, Chengqun Sun, Jessica L Farren, Michelle M Marti, Alyssa L Lee, Thomas Donovan, Robyn S Klein, Dhivyaa Rajasundaram, William B Klimstra

Abstract read
In one paragraph

Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Melaina L JacobyDepartment of Infectious Diseases and Microbiology, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania, United States of America.ORCID 0009-0004-3372-4491
Chengqun SunDepartment of Immunology and Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
Jessica L FarrenDepartment of Immunology and Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
Michelle M MartiDepartment of Infectious Diseases and Microbiology, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania, United States of America.
Alyssa L LeeInstitute for Quantitative Biomedicine, Rutgers University, New Brunswick, New Jersey, United States of America.
Thomas DonovanDepartment of Pediatrics, Division of Health Informatics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.
Robyn S KleinDepartments of Internal Medicine, Microbiology and Immunology, Western Institute of Neuroscience, Western University, London, Ontario, Canada.
Dhivyaa RajasundaramDepartment of Pediatrics, Division of Health Informatics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.
William B KlimstraDepartment of Immunology and Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.ORCID 0000-0003-4506-7842

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHRISTOPHER J. BAKKENIST · 1988 to 2026
$158.0M
Practices CoreUC7AI180311 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI William Paul Duprex · 2023 to 2026
$13.2M
An Informed Approach to Live Attenuated Vaccines against Encephalitis AlphavirusesR01AI153209 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KLIMSTRA, WILLIAM B · 2020 to 2024
$2.9M
Viral and host factors in neuroinvasion of encephalitis alphavirusesR01AI160188 · NIAID · WASHINGTON UNIVERSITY · PI WILLIAM B KLIMSTRA, Robyn S. Klein · 2022 to 2026
$2.8M
High-Throughput Computing for Genomics and Bioinformatics ResearchS10OD028483 · OD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LEE, ADRIAN V · 2021 to 2021
$574k
NCI NIH HHS P30 CA047904NIAID NIH HHS R01 AI153209NIAID NIH HHS R01 AI160188NIAID NIH HHS UC7 AI180311NIH HHS S10 OD028483
6 · The paper itself

Abstract

Systemic type I interferon (IFN-I) and pro-inflammatory cytokine responses are critical for limiting mosquito-borne RNA virus viral replication and disease, yet mechanisms initiating these responses and their linkage to viral tropism for lymphoid tissues are poorly understood. Here, we reveal that virus-cell interactions and specific host signaling pathways in lymphoid tissues are determinants of systemic cytokine induction. Using Venezuelan equine encephalitis virus (VEEV) mutants with defined lymph node (LN) tropism in mice, we show that VEEV LN infection positively associates with systemic IFN-I and other proinflammatory cytokine induction. Maximal responses require coordinated activation of multiple IRF7-dependent Toll-like receptor and RIG-I-like receptor pathways. Combining targeted cell depletion and Visium HD spatial transcriptomics viral gene quantitation, we uncover a spatiotemporal, biphasic innate immune response to VEEV infection, with initial cytokine induction driven by VEEV replication in dendritic cell and monocyte/macrophage subtypes within the LN subcapsular sinus. Surprisingly, active virus replication is curtailed in this LN compartment before 16hpi, when cytokine induction becomes dominated by non-VEEV-replicating bystander cells including plasmacytoid dendritic cells. These findings have direct implications for intervention against viral diseases characterized by lymphoid infection and subsequent spread to sites of terminal disease.

Indexed as

Encephalitis Virus, Venezuelan EquineEncephalomyelitis, Venezuelan EquineVirus ReplicationAnimalsCytokinesDendritic CellsImmunity, InnateInterferon Type ILymph NodesMiceMice, Inbred C57BLCytokinesInterferon Type I

Identifiers

PMID42585262
PMCPMC13561425

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.